Key result
CRISPR screening identifies chromatin remodelers driving fibrotic transformation, with Wdr82 depletion cutting collagen secretion ~3-fold.
Why the study?
The roles of chromatin factors in myofibroblast differentiation and their contribution to pathogenic cardiac fibrosis remain poorly understood.
Does KAT5 inhibition alleviate fibrotic responses in patient-derived human fibroblasts?
Does KAT5 inhibition alleviate fibrotic responses in patient-derived human fibroblasts?
The study identifies Srcap and Kat5 as key epigenetic regulators of cardiac fibrosis and demonstrates that KAT5 inhibition reduces fibrotic responses in human fibroblasts, offering a potential therapeutic target.
KAT5 inhibition may attenuate fibrosis in fibroblasts; leaves open translation to cardiac disease models or patients.
Cardiac fibrosis is mediated by the persistent activity of myofibroblasts, which differentiate from resident cardiac fibroblasts in response to tissue damage and stress signals. The signaling pathways and transcription factors regulating fibrotic transformation have been thoroughly studied. In contrast, the roles of chromatin factors in myofibroblast differentiation and their contribution to pathogenic cardiac fibrosis remain poorly understood. Here, we combined bulk and single-cell CRISPR screens to characterize the roles of chromatin factors in the fibrotic transformation of primary cardiac fibroblasts. We uncover strong regulators of fibrotic states including Srcap and Kat5 chromatin remodelers. We confirm that these factors are required for functional processes underlying fibrosis including collagen synthesis and cell contractility. Using chromatin profiling in perturbed cardiac fibroblasts, we demonstrate that pro-fibrotic chromatin complexes facilitate the activity of well-characterized pro-fibrotic transcription factors. Finally, we show that KAT5 inhibition alleviates fibrotic responses in patient-derived human fibroblasts.
No takes yet. Share an insight, caveat, or question.
Aguado‐Alvaro et al. (2025) studied Cardiac fibrosis. CRISPR-Cas9 knockout of epigenetic regulators vs. Non-targeting control (NTC) was evaluated on Fibrotic transformation (PDGFRα surface expression and collagen secretion). CRISPR screening identified chromatin remodelers, including Srcap, Kat5, and Wdr82, as essential regulators of fibrotic transformation, with Wdr82 depletion reducing collagen secretion by 3-fold.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: